Pharming PHAR Earnings Call Transcripts

NASDAQ PHAR
$13.02 -0.14 (-1.06%)
As of: Nov 10, 2026 · 10:59 AM EST
2 earnings calls on file for Pharming, from Q2 2026 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Pharming Q3 2026 Earnings Call

Oct 27, 2026 6,248 words · 27 min read
  • Kenneth LynardInterim Co-Chief Executive Officer
  • Leverne MarshInterim Co-Chief Executive Officer and Chief Commercial Officer
  • Anurag RelanChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Pharming Earnings Call Transcripts

Calls2
LatestOct 27, 2026
SinceQ2 2026

Fiscal 2026

All 2 Pharming transcripts Register to get access to Pharming’s earnings call transcripts.